A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors Read more about A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors
Study of CG0070 Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin Read more about Study of CG0070 Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients Read more about I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
The Tether™ - Vertebral Body Tethering System Post Approval Study Read more about The Tether™ - Vertebral Body Tethering System Post Approval Study
A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer Read more about A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing Read more about A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) Read more about To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa Read more about Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa
Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab for NSCLC With KRAS G12C Mutation KRYSTAL-7 Read more about Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab for NSCLC With KRAS G12C Mutation KRYSTAL-7
Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome Read more about Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome